An Analysis of Adjuvant Treatment Strategies for Carcinoma of the Cervix
- 1 October 1989
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 12 (5) , 430-433
- https://doi.org/10.1097/00000421-198910000-00014
Abstract
The majority of women with cancer of the cervix are cured with radiation or surgery, but a sizable fraction of tumors recur. Adjuvant chemotherapy is generally toxic and of limited efficacy. Thus, 49 women with surgical staging and estrogen and progesterone receptors were analyzed with logistic models to identify patients at high and low risk of treatment failure following conventional therapy. This methodology allows the patient and her physician to optimize choice of therapy. The benefits and limitations of such a decision theory analysis are discussed.This publication has 8 references indexed in Scilit:
- Combination chemotherapy prior to radical radiotherapy for Stage III and IV carcinoma of the cervixClinical Radiology, 1987
- Neoadjuvant therapy for advanced squamous cell carcinoma of the cervix: Cisplatin followed by radiation therapy—A pilot study of the gynecologic oncology groupGynecologic Oncology, 1987
- Prognostic importance of progesterone and estrogen receptors in cancer of the uterine cervixCancer, 1986
- Effect of cis-Platinum on Tolerance to Radiation Therapy in Advanced Cervical CancerAmerican Journal of Clinical Oncology, 1986
- The influence of estrogen and progesterone receptors on survival in patients with carcinoma of the uterine cervixGynecologic Oncology, 1986
- Therapeutic implications of the natural history of advanced cervical cancer as defined by pretreatment surgical stagingCancer, 1985
- III. Application of Principles of Test Selection and InterpretationAnnals of Internal Medicine, 1981
- EFFECT OF 17-ALPHA-HYDROXYPROGESTERONE 17-N-CAPROATE ON VARIOUS PELVIC MALIGNANCIES1964